ClinicalTrials.Veeva

Menu

Hemiarch vs Extended Arch in Type 1 Aortic Dissection (HEADSTART)

U

University of Ottawa Heart Institute

Status

Enrolling

Conditions

Aortic Dissection

Treatments

Procedure: Hemiarch repair
Procedure: Extended arch repair

Study type

Interventional

Funder types

Other

Identifiers

NCT03885635
HEADSTART

Details and patient eligibility

About

HEADSTART is a prospective, open-label, non-blinded, multicenter, randomized controlled trial that compares a composite of mortality and re-intervention in patients undergoing hemiarch and extended arch repair for acute DeBakey type 1 aortic dissection. Eligible patients will be randomized to one or the other surgical strategy and clinical and imaging outcome data will be collected over a 3 year follow up period.

Full description

DeBakey Type 1 aortic dissections continue to have high operative mortality and morbidity and there is equipoise in available literature with regards to the best operative strategy and patient selection criteria. Hemiarch repair is current standard of care in most centers but extended arch repair is gaining popularity aiming to address early post-operative malperfusion and improve long term aortic remodeling.

HEADSTART is a randomized controlled prospective trial of patients presenting to participating institutes with acute DeBakey 1 aortic dissection. Patients will be enrolled and randomized into one of two groups - 'hemiarch repair' and 'extended arch repair'. Pre-operative, early post-operative and long term follow clinical and CT imaging data will be collated on a centralized database and at a core lab respectively.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  1. Emergent surgical repair of Acute DeBakey Type 1 aortic dissection
  2. Age >18 years and <70 years
  3. Operating surgeon believes that both surgeries could be safe and effective

Exclusion Criteria

  1. Hemodynamic instability/shock defined as systolic BP < 90 mm Hg
  2. Previous cardiac surgery with sternotomy or thoracic endograft placement
  3. Aortic arch diameter > 6cm in which a concomitant arch replacement is judged necessary
  4. Procedures deemed to be "salvage operations" where the patient is unlikely to survive hospital discharge.
  5. GCS < 8 for more than 6 hours
  6. History of cirrhosis.
  7. History of chronic renal failure (baseline eGFR < 50)
  8. Metastatic malignancy
  9. Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Hemiarch repair
Active Comparator group
Description:
Standard hemiarch repair with open distal anastomosis in the proximal arch without replacement of the head vessels.
Treatment:
Procedure: Hemiarch repair
Extended arch repair
Active Comparator group
Description:
Ascending aortic and arch replacement with or without head vessel re-implantation and single TEVAR device placement within 1 week.
Treatment:
Procedure: Extended arch repair

Trial contacts and locations

4

Loading...

Central trial contact

Khatira Mehdiyeva; Alice Black

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems